Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

BACKGROUND/AIMS: The clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these variables to create individual IFX treatment strategies for patients with pedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, So Yoon, Kang, Ben, Lee, Jee Hyun, Choe, Yon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221861/
https://www.ncbi.nlm.nih.gov/pubmed/27609485
http://dx.doi.org/10.5009/gnl16041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221861/
https://www.ncbi.nlm.nih.gov/pubmed/27609485
http://dx.doi.org/10.5009/gnl16041

Ejemplares similares